TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE

Last Updated: 31 Jan 2025

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE is ACRA -registered entity that has been operating for 21 years 6 months in Singapore since its incorporation in 2003.

Officially, TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE is registered as Private Limited Company with its address 20 ANSON ROAD, #05-03, TWENTY ANSON, Singapore 079912.

Country of registration	Singapore
Registration number	200312886D
Local SIC	46461: Wholesale of medicinal and pharmaceutical products (Western)
Incorporation date	17 Dec 2003
Company age	21 years 6 months
Official entity type	Private Limited Company
No. of officers	26

Contact

Address:

20 ANSON ROAD, #05-03, TWENTY ANSON, Singapore 079912

Phone number:

Access Key Decision Makers

This is the legal entity page of TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.

Associated business (1)

TEVA PHARMACEUTICALS
Israel
View More
oncology
generic medicines
specialty medicines
cns
biologics
biosimilars
active pharmaceutical ingredients
respiratory
pain care
migraine
Pharmaceuticals
Manufacturing
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:

This is the legal entity page of TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.

Financials

Fiscal/Budgeting Period	October - December
Auditor	PRICEWATERHOUSECOOPERS LLP
Revenue	26m - 50m
Financial period end date	31 Dec 2021
Share Capital - Ordinary shares	USD 187,114,508
Share Capital - Ordinary shares	SGD 2

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE?
Where is TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE's headquarter?
What is TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE's contact number?
What TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE's spending power?
Does TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE have a presence in the domain it operates in?